NM_018714.3:c.903G>C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_018714.3(COG1):​c.903G>C​(p.Gln301His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00815 in 1,614,104 control chromosomes in the GnomAD database, including 67 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0052 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0085 ( 65 hom. )

Consequence

COG1
NM_018714.3 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 1.25

Publications

12 publications found
Variant links:
Genes affected
COG1 (HGNC:6545): (component of oligomeric golgi complex 1) The protein encoded by this gene is one of eight proteins (Cog1-8) which form a Golgi-localized complex (COG) required for normal Golgi morphology and function. It is thought that this protein is required for steps in the normal medial and trans Golgi-associated processing of glycoconjugates and plays a role in the organization of the Golgi-localized complex. [provided by RefSeq, Jul 2008]
COG1 Gene-Disease associations (from GenCC):
  • COG1-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, PanelApp Australia, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003544867).
BP6
Variant 17-73197386-G-C is Benign according to our data. Variant chr17-73197386-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 95920.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00517 (787/152316) while in subpopulation NFE AF = 0.00764 (520/68038). AF 95% confidence interval is 0.0071. There are 2 homozygotes in GnomAd4. There are 359 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COG1NM_018714.3 linkc.903G>C p.Gln301His missense_variant Exon 4 of 14 ENST00000299886.9 NP_061184.1 Q8WTW3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COG1ENST00000299886.9 linkc.903G>C p.Gln301His missense_variant Exon 4 of 14 1 NM_018714.3 ENSP00000299886.4 Q8WTW3
COG1ENST00000438720.7 linkc.900G>C p.Gln300His missense_variant Exon 4 of 13 1 ENSP00000400111.3 E9PBL8

Frequencies

GnomAD3 genomes
AF:
0.00518
AC:
788
AN:
152198
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00140
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.0199
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00800
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00764
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00559
AC:
1405
AN:
251376
AF XY:
0.00576
show subpopulations
Gnomad AFR exome
AF:
0.00142
Gnomad AMR exome
AF:
0.00130
Gnomad ASJ exome
AF:
0.0177
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00686
Gnomad NFE exome
AF:
0.00781
Gnomad OTH exome
AF:
0.00440
GnomAD4 exome
AF:
0.00846
AC:
12365
AN:
1461788
Hom.:
65
Cov.:
35
AF XY:
0.00829
AC XY:
6029
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.00155
AC:
52
AN:
33480
American (AMR)
AF:
0.00154
AC:
69
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0192
AC:
502
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00335
AC:
289
AN:
86258
European-Finnish (FIN)
AF:
0.00714
AC:
381
AN:
53332
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.00957
AC:
10643
AN:
1111996
Other (OTH)
AF:
0.00702
AC:
424
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
686
1372
2058
2744
3430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00517
AC:
787
AN:
152316
Hom.:
2
Cov.:
33
AF XY:
0.00482
AC XY:
359
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00140
AC:
58
AN:
41566
American (AMR)
AF:
0.00183
AC:
28
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0199
AC:
69
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5176
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4828
European-Finnish (FIN)
AF:
0.00800
AC:
85
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00764
AC:
520
AN:
68038
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
44
89
133
178
222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00566
Hom.:
3
Bravo
AF:
0.00456
TwinsUK
AF:
0.00944
AC:
35
ALSPAC
AF:
0.0101
AC:
39
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00826
AC:
71
ExAC
AF:
0.00529
AC:
642
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00752
EpiControl
AF:
0.00765

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 09, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

COG1: BP4, BS2 -

COG1 congenital disorder of glycosylation Uncertain:1Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not specified Benign:2
Oct 11, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 10, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

COG1-related disorder Benign:1
Jul 09, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
22
DANN
Benign
0.92
DEOGEN2
Benign
0.031
T;T
Eigen
Uncertain
0.20
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.72
T;T
M_CAP
Benign
0.0066
T
MetaRNN
Benign
0.0035
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.6
.;M
PhyloP100
1.2
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-2.1
.;N
REVEL
Benign
0.076
Sift
Benign
0.037
.;D
Sift4G
Benign
0.096
T;T
Polyphen
0.96
.;D
Vest4
0.16
MutPred
0.20
Gain of methylation at K306 (P = 0.1636);Gain of methylation at K306 (P = 0.1636);
MVP
0.36
MPC
0.098
ClinPred
0.011
T
GERP RS
3.3
Varity_R
0.067
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117208167; hg19: chr17-71193525; COSMIC: COSV100245394; COSMIC: COSV100245394; API